freestyle libre flash glucose monitoring system.

#Freestyle libre flash glucose monitoring system. skin
#Freestyle libre flash glucose monitoring system. professional

The FreeStyle Libre system is designed to be water-resistant and can be worn while bathing, showering, swimming and exercising.

The sensor automatically measures and continuously stores glucose readings day and night.

Using the supplied disposable applicator, the freestyle libre sensor can be easily applied and stays on the back of your upper arm for upto 14 days.

The FreeStyle Libre reader can capture data from within 1cm to 4cm of the sensor, even through clothing

Get glucose readings with a painless one-second scan. Trusted Shipping to Riyadh, Jeddah and all KSA Great Prices Secure Shopping 100 Contactless Easy Free.

The reader stores 90 days of glucose data, so you can see a complete picture of your glucose levels over 3 months.

Each scan of the reader shows the current glucose reading, the last 8 hours of data and a trend arrow indicating if glucose is going up, down or staying steady.

This starter combination pack containing a sensor and a reader is to get you started on the Freestyle Libre System. Just scan the reader over the sensor worn on the back of your upper arm to check your glucose levels. It is a 3 in one device – Continuous Glucose Monitor, Blood Glucose Tester and Blood Ketone Tester.The FreeStyle Libre system liberates you from the hassles of routine finger prick testing.

Subject is unsuitable for participation due to any other cause as determined by the Investigator.The reader is a one-time purchase and can be used for life.

Subject has X-ray, MRI, CT or diathermy appointment scheduled during the period of study participation, and the appointment cannot be rescheduled for a time before study participation starts or after study participation ends.

Such conditions include but are not limited to:

Subject has concomitant medical condition which, in the opinion of the investigator, could present a risk to the safety or welfare of the subject or study staff.

Subject has both hemoglobin (Hb) and hematocrit levels that are 10% or more below the normal ranges (For reference low end of the normal range for Hb for males is 14 g/dL and for females is 12 g/dL low end of the normal hematocrit is 40% for men and 36% for women).

Subject has donated blood within 112 days (3.7 months) prior to the beginning of the study activities.

Subject is currently participating in another clinical trial.

EMT assistance, emergency room visit, or hospital admission) within the last three (3) months.

#Freestyle libre flash glucose monitoring system. professional

Subject has had an episode of severe hypoglycemia requiring intervention from a health care professional (i.e.

#Freestyle libre flash glucose monitoring system. skin

Such conditions include, but are not limited to extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, dermatitis herpetiformis, skin lesions, redness, infection or edema. Subject has extensive skin changes/diseases at the proposed application sites that could interfere with device placement or the accuracy of interstitial glucose measurements.Subject is pregnant, attempting to conceive or not willing and able to practice birth control during the study duration (applicable to female subjects only).Subject has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin.Subject has a history of hypoglycemia unawareness.Additional criteria for hypoglycemia induction.Subject must be willing and able to provide written signed and dated informed consent.At the time of enrollment, subject must be available to participate in all study visits.In the investigator's opinion, the subject must be able to follow the instructions provided to him/her by the study site and perform all study tasks as specified by the protocol.Willing to have their blood sugar manipulated during in-clinic sessions.Subject must be able to read and understand English.

Willing to perform a minimum of 8 finger sticks per day while wearing the sensor in the study.Subject must require insulin therapy through an insulin pump and/or multiple daily insulin injections (at least 3 injections daily).Subject must have type 1 or type 2 diabetes.Subject must be at least 18 years of age.Why Should I Register and Submit Results?.